# A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus

> **NCT00873561** · PHASE1 · COMPLETED · sponsor: **Neurocrine Biosciences** · enrollment: 188 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** NBI-6024

## Key facts

- **NCT ID:** NCT00873561
- **Lead sponsor:** Neurocrine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2006-04
- **Final completion:** 2006-07
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2009-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00873561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00873561, "A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00873561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*